نتائج البحث - Johan Richter

تنقيح النتائج
  1. 1
    Towards a better understanding and new therapeutics of osteopetrosis

    Towards a better understanding and new therapeutics of osteopetrosis حسب Maria Askmyr, Anders Fasth, Johan Richter

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation.

    Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. حسب Johan Richter, Tommy Andersson, I. Anna S. Olsson

    منشور في 1989
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+.

    Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+. حسب Johan Richter, Janet Ng-Sikorski, Inge Olsson, Tommy Andersson

    منشور في 1990
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The concept of treatment-free remission in chronic myeloid leukemia

    The concept of treatment-free remission in chronic myeloid leukemia حسب Susanne Saußele, Johan Richter, Andreas Hochhaus, F-X Mahon

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Optical touch pointer for fluorescence guided glioblastoma resection using 5‐aminolevulinic acid

    Optical touch pointer for fluorescence guided glioblastoma resection using 5‐aminolevulinic acid حسب Neda Haj‐Hosseini, Johan Richter, Stefan Andersson‐Engels, Karin Wårdell

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Ribosomal Protein S19 Deficiency Leads to Reduced Proliferation and Increased Apoptosis but Does Not Affect Terminal Erythroid Differentiation in a Cell Line Model of Diamond-Blackfan Anemia

    Ribosomal Protein S19 Deficiency Leads to Reduced Proliferation and Increased Apoptosis but Does Not Affect Terminal Erythroid Differentiation in a Cell Line Model of Diamond-Black... حسب Koich Miyake, Taiju Utsugisawa, Johan Flygare, Thomas Kiefer, Isao Hamaguchi, Johan Richter, Stefan Karlsson

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes

    Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes حسب Henrik Löfvall, Hannah Newbould, M.A. Karsdal, Morten Hanefeld Dziegiel, Johan Richter, Kim Henriksen, Christian S. Thudium

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib

    RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib حسب Henrik Lilljebjörn, Helena Ågerstam, Christina Orsmark‐Pietras, Marianne Rissler, Hans Ehrencrona, L. Nilsson, Johan Richter, Thoas Fioretos

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up حسب Andreas Hochhaus, Susanne Saußele, Gianantonio Rosti, F-X Mahon, J. Janssen, Henrik Hjorth‐Hansen, Johan Richter, Christian Buske

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Effective cell and gene therapy in a murine model of Gaucher disease

    Effective cell and gene therapy in a murine model of Gaucher disease حسب Ida Enquist, Eva Nilsson, Andreas Ooka, Jan‐Eric Månsson, Karin Olsson, Mats Ehinger, Roscoe O. Brady, Johan Richter, Stefán Karlsson

    منشور في 2006
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner

    Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner حسب Pablo Peña‐Martínez, Mia Eriksson, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Christina Orsmark‐Pietras, Johan Richter, Anna Andersson, Thoas Fioretos, Marcus Järås

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome

    IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome حسب Niklas Landberg, Nils Hansen, Maria Askmyr, Helena Ågerstam, Carin Lassen, Marianne Rissler, Henrik Hjorth‐Hansen, Satu Mustjoki, Marcus Järås, Johan Richter, Thoas Fioretos

    منشور في 2015
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Murine models of acute neuronopathic Gaucher disease

    Murine models of acute neuronopathic Gaucher disease حسب Ida Enquist, Christophe Lo Bianco, Andreas Ooka, Eva Nilsson, Jan‐Eric Månsson, Mats Ehinger, Johan Richter, Roscoe O. Brady, Deniz Kirik, Stefan Karlsson

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein

    Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein حسب Marcus Järås, Petra Johnels, Nils Hansen, Helena Ågerstam, Panagiotis Tsapogas, Marianne Rissler, Carin Lassen, Tor Olofsson, Ole Weis Bjerrum, Johan Richter, Thoas Fioretos

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

    The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses حسب Lisa Christiansson, Stina Söderlund, Sara M. Mangsbo, Henrik Hjorth‐Hansen, Martin Höglund, Berit Markevärn, Johan Richter, Leif Stenke, Satu Mustjoki, Angelica Loskog, Ulla Olsson‐Strömberg

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry حسب Anna Lübking, Arta Dreimane, Fredrik Sandin, Cecilia Isaksson, Berit Markevärn, Mats Brune, Per Ljungman, Stig Lenhoff, Leif Stenke, Martin Höglund, Johan Richter, Ulla Olsson‐Strömberg

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting

    CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting حسب Niklas Landberg, Sofia von Palffy, Maria Askmyr, Henrik Lilljebjörn, Carl Sandén, Marianne Rissler, Satu Mustjoki, Henrik Hjorth‐Hansen, Johan Richter, Helena Ågerstam, Marcus Järås, Thoas Fioretos

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era

    Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era حسب Niklas Gunnarsson, Leif Stenke, Martin Höglund, Fredrik Sandin, Magnus Björkholm, Arta Dreimane, Mats Lambe, Berit Markevärn, Ulla Olsson‐Strömberg, Johan Richter, Hans Wadenvik, Jonas Wallvik, Anders Själander

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia

    Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia حسب Pekka Jaako, Johan Flygare, Karin Olsson, Ronan Quéré, Mats Ehinger, Adrianna Henson, Steven R. Ellis, Axel Schambach, Christopher Baum, Johan Richter, Jonas Larsson, David Bryder, Stefan Karlsson

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

    Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008 حسب Magnus Björkholm, Lotta Ohm, Sandra Eloranta, Åsa Rangert Derolf, Malin Hultcrantz, Jan Sjöberg, Therése Andersson, Martin Höglund, Johan Richter, Ola Landgren, Sigurður Y. Kristinsson, Paul W. Dickman

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: